<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[pharmalot Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/pharmalot.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to pharmalot]]></description>
	<s:counts start="0" returned="4" found="4" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Pharmalot's Ed Silverman: The Exit Interview]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000561/pharmalots-ed-silverman-the-exit-interview/]]></link>
		<description><![CDATA[On Monday, Pharmalot's Ed Silverman shocked the pharmaceutical business by returning from vacation and announcing that his blog was no more. Over the past two years, Pharmalot grew into the premier supplier of aggregated drug news and a formidable producer of original content even BNET took the Pharmalot feed. In...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 06 Jan 2009 12:58:37 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/exit+interview.html"><![CDATA[Exit Interview]]></category>
		<category domain="http://resources.bnet.com/topic/blog.html"><![CDATA[Blog]]></category>
		<category domain="http://resources.bnet.com/topic/pharmalot.html"><![CDATA[Pharmalot]]></category>
		<category domain="http://resources.bnet.com/topic/es.html"><![CDATA[ES]]></category>
		<category domain="http://resources.bnet.com/topic/blogging.html"><![CDATA[Blogging]]></category>
		<category domain="http://resources.bnet.com/topic/internet.html"><![CDATA[Internet]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[Pharma Roundup: Pfizer's Acquisition Plans, Prasugrel's Big Day, and More]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000555/pharma-roundup-pfizers-acquisition-plans-prasugrels-big-day-and-more/]]></link>
		<description><![CDATA[Pfizer wants acquisitions, big and small. Prasugrel has a date with the FDA. New Year's blog feature bonanza. Farewell, Pharmalot. by John Maas]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Mon, 05 Jan 2009 17:09:28 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/acquisition.html"><![CDATA[Acquisition]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/lilly.html"><![CDATA[Lilly]]></category>
		<category domain="http://resources.bnet.com/topic/pharmalot.html"><![CDATA[Pharmalot]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Europeans Chew on Pfizer's Chantix as Americans Turn Away]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000324/europeans-chew-on-pfizers-chantix-as-americans-turn-away/]]></link>
		<description><![CDATA[Pfizer's smoking cessation product, Chantix, seems to be going down the path of Exubera in the U.S.: Sales were down 49 percent to $96 million in America, and down globally by 24 percent to $182 million, making it a marginal drug for Pfizer.    But in foreign territories,...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 22 Oct 2008 11:23:08 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmalot.html"><![CDATA[Pharmalot]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmalot.html"><![CDATA[Pharmalot]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Pharma's Future Leaders -- Or Its Pallbearers]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000105/pharmas-future-leaders-or-its-pallbearers/]]></link>
		<description><![CDATA[Given the challenges facing Big Pharma -- expiring patents, waning drug pipelines, the imploding blockbuster model, and increasing political pressure on its marketing practices -- it's hard not to wonder sometimes just who in their right minds would want to lead its giant but fragile companies over the next decade...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 24 Jun 2008 21:54:43 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/amgen+inc..html"><![CDATA[Amgen Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/gilead+sciences+inc..html"><![CDATA[Gilead Sciences Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/leader.html"><![CDATA[Leader]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/pharmalot.html"><![CDATA[Pharmalot]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[Biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/david+p.+hamilton.html"><![CDATA[David P. Hamilton]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMGN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GILD</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">AMGN,GILD,MRK</category>
	</item>
</channel>
</rss>
